Tonghua Dongbao Pharmaceutical Co., Ltd.

Sümbol: 600867.SS

SHH

10.3

CNY

Turuhind täna

18.2244
P/E suhe
0.0089
PEG suhe
20.25B
MRK Cap
0.02%
DIV tootlus

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Tonghua Dongbao Pharmaceutical Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	1159.7	846.5	902	743.7	368	356	336.4	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	18.6	9.5	8.9	28.3	14.3	4.1	19	6.1	9.8	54.1	132.6	161.2	17.1	34.6	0
balance-sheet.row.short-term-investments	55.5	58.5	37	150.4	-73	-58.8	-29.7	-14.7	-16.3	-17.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	916.8	515.4	707.3	623.7	724.2	677.2	605.3	519.3	455.7	480.2	535.1	595.5	712.1	560	618.3	626.4	544.2	515.7	835.4	834.4	969.9	1021.6	850.2	127.5	131.8	0.4	0.2	4.1	5.6	0
balance-sheet.row.inventory	705.3	653.9	537.9	537.6	628.8	901	973.9	1047.9	954.8	629.6	343.8	233	197.8	187.4	170.1	145.6	145.5	140.1	139.8	140.6	126.6	95.9	98.5	73	53.4	35.1	23.9	25.3	13.4	0
balance-sheet.row.other-current-assets	34.5	40.5	15.2	17.4	205.6	339	324.3	406.9	11.2	0.1	12.5	-84.5	-99.9	-79.2	-113.6	-119.4	-89.2	-77.2	-218.5	-248.9	-310.9	-347.8	-220.4	642.3	664.2	526.3	488	258.1	192.1	205.6
balance-sheet.row.total-current-assets	2816.4	2056.4	2162.5	1922.4	1926.6	2273.2	2240	2209.8	1633.9	1311.8	1107.4	868.6	1053.9	731	721.5	671.2	610	587.6	785	740.3	789.7	788.8	734.3	852.6	903.5	694.5	673.4	304.6	245.7	205.6
balance-sheet.row.property-plant-equipment-net	2704.4	2678.4	2392.1	2287.6	2111	1959.7	1873.4	1851.4	1586.9	1279.9	1259.7	1233.2	1087.1	1147.9	1180.2	1226.9	1224.2	1099.5	873.7	807.7	732.1	673.1	622.3	515.2	478.9	387	185.3	174.5	75.7	43.5
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1338.3	1069.1	796.6	608.8	472.6	388.6	193.6	198.7	102	81.8	80.9	69.1	69.5	77.8	84.9	93.3	104.3	94.3	23.9	32	31.2	30.6	34.7	33	72.1	73.2	9.1	9.8	5.6	0
balance-sheet.row.goodwill-and-intangible-assets	1338.3	1069.1	796.6	608.8	472.6	388.6	193.6	198.7	102	81.8	80.9	69.1	69.5	77.8	84.9	98.2	109.2	94.3	23.9	32	31.2	30.6	34.7	33	72.1	73.2	9.1	9.8	5.6	0
balance-sheet.row.long-term-investments	534.2	304	420.9	311.4	428.8	385	368.3	334.3	195.5	246.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	38.6	46.2	42.4	37.7	37.8	36.2	39	44.1	44	35.6	28.4	30.5	21	20.7	20.7	21.6	28.1	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	339.6	596.2	705.6	635.3	373.1	420.6	38.4	36.8	225.8	0.5	218	178.8	145.8	209	244.2	153.4	297.5	185.7	202.3	226.2	242.1	76.1	65.2	68.3	42.9	24	7.5	7	0.5	17.4
balance-sheet.row.total-non-current-assets	4955	4693.9	4357.6	3880.8	3423.3	3190.1	2512.7	2465.2	2154.3	1644.5	1587	1511.5	1323.4	1455.3	1530	1500.1	1659	1379.5	1099.9	1065.9	1005.4	779.8	722.2	616.5	593.9	484.2	201.9	191.3	81.8	60.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.2	0	0	0
balance-sheet.row.total-assets	7771.4	6750.3	6520.1	5803.3	5349.9	5463.3	4752.7	4675	3788.1	2956.2	2694.5	2380.1	2377.3	2186.3	2251.4	2171.3	2269	1967.1	1885	1806.2	1795.1	1568.5	1456.5	1469.1	1497.4	1178.7	875	495.9	327.5	266.5
balance-sheet.row.account-payables	115.9	80.9	75	68.2	69.2	132	61.3	90.5	53.2	52	38.9	30.8	37.8	46.7	40.7	49.5	40.8	43.1	44.4	45.2	40.7	39.7	29.3	28.7	19.9	25	20.5	20.7	13.6	0
balance-sheet.row.short-term-debt	150	-21.1	-7.9	-8.2	125	450	0	430	872.8	310	283	79	93	64	223	321.7	324.1	251.7	337.9	271.5	249.2	3.2	3.2	3.4	45.9	23	1.7	7.3	0	0
balance-sheet.row.tax-payables	52.5	13.2	111.6	55.5	50.9	40	34.7	20.4	11.7	15.5	14.9	-5.5	4.3	20.5	4	8	12.2	33.7	27.1	17.8	8.8	13.5	4.6	-1.4	-1.2	3.8	3.8	3.9	5.4	0
balance-sheet.row.long-term-debt-total	0	2.6	2.6	2.6	2.6	4	0	60	250	298	256.4	238.8	122	266.6	269.1	269.6	270.1	270.1	48.2	99.5	49.5	49.5	0	0	14.3	15	28.6	11.5	0	0
Deferred Revenue Non Current	27.5	28.5	28.7	32.9	33.4	33.7	35	24.2	24.5	24	-211.4	-226.9	-108.9	-252.1	-251.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	243.8	81.2	193.6	140	29.9	69.4	113.7	5.4	2	3.3	16.3	11.8	12.1	9	11.8	6.8	6.5	6.4	2.7	9.4	6.3	3.9	6.5	2.9	0.5	1	0.8	1.1	60.3	23.5
balance-sheet.row.total-non-current-liabilities	7.4	38.7	31.3	35.6	36.3	37.7	40.3	90.7	282.4	335.1	303.2	252.9	136	284.6	303.5	312.9	313.4	315.6	94	100.3	50.9	52	1.7	0	14.4	15	28.6	11.5	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	527.6	200.7	299.9	243.8	341.1	729.1	215.3	729.8	1309.1	795.7	678.2	388.9	299.4	453.7	624.7	737.7	735	691.1	544.2	480.1	393.9	205.5	78	44.1	92.8	249.8	64.7	51.6	73.9	23.5
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1993.6	1993.7	2034	2034	2034	2034	1711.3	1421.9	1135.8	1030.1	931.5	776.2	776.2	575	479.1	368.6	368.6	368.6	324.5	324.5	324.5	324.5	324.5	324.5	324.5	208	208	115.6	92.4	77.8
balance-sheet.row.retained-earnings	3697.4	3025.5	2700.5	1951.1	1531.1	1208.4	1130.3	942.3	819.9	686.3	716.5	708.3	808.8	482.7	320.1	252.8	212.2	110.5	100.3	87.6	167.8	138.5	190	234.5	196.6	170	91.9	73.8	5.7	26.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	1003.4	1188.1	1039.9	863.5	662.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	516.8	336.9	440.4	705.5	772.5	1481.9	1686.3	1575	503.6	421.4	343.2	477.2	461	641.9	793.6	772.4	911.2	754	871.4	867.8	865.9	859.1	857.6	859	850.6	524.9	510.5	255	155.5	138.5
balance-sheet.row.total-stockholders-equity	7211.2	6544.3	6214.9	5554	5000.4	4724.3	4527.9	3939.2	2459.3	2137.7	1991.2	1961.7	2046	1699.6	1592.9	1393.8	1492	1233.1	1296.1	1279.9	1358.2	1322	1372.1	1417.9	1371.6	902.9	810.3	444.4	253.6	243
balance-sheet.row.total-liabilities-and-stockholders-equity	7771.4	6750.3	6520.1	5803.3	5349.9	5463.3	4752.7	4675	3788.1	2956.2	2694.5	2380.1	2377.3	2186.3	2251.4	2171.3	2269	1967.1	1885	1806.2	1795.1	1568.5	1456.5	1469.1	1497.4	1178.7	875	495.9	327.5	266.5
balance-sheet.row.minority-interest	5.1	5.3	5.3	5.5	8.4	10	9.6	6	19.7	22.8	25	29.5	31.9	32.9	33.8	39.8	42	42.9	44.6	46.2	43	41	6.5	7.1	33	26	0	0	0	0
balance-sheet.row.total-equity	7216.3	6549.6	6220.2	5559.5	5008.8	4734.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	589.8	362.5	457.9	461.8	355.8	326.2	338.6	319.6	179.2	228.8	213.4	173	138.9	209	244.2	153.4	297.5	162.3	202.3	226.2	242.1	76.1	65.2	63.9	38.4	21.7	0	0	0.5	0
balance-sheet.row.total-debt	150	2.6	2.6	2.6	125	450	0	490	1122.8	608	539.4	317.8	215	330.6	492.1	591.3	594.1	521.8	386.1	371	298.7	52.7	3.2	3.4	60.2	38	30.3	18.9	0	0
balance-sheet.row.net-debt	-954.2	-785.4	-862.4	-590.7	-243	94	-336.4	254.4	910.6	406.1	323.3	193.2	-29	267.8	445.4	572.6	584.6	512.9	357.7	356.7	294.6	33.7	-2.9	-6.4	6.1	-94.6	-130.9	1.8	-34.6	0

Rahavoogude aruanne

Tonghua Dongbao Pharmaceutical Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1167.8	1581.8	1308.6	930.3	809.6	838.9	840.1	639.2	490.1	276.5	179.5	59.6	363	173.4	67.7	44.6	75.7	13.3	18	-74.8	38.2	44.4	31	48	71.5	90.7
cash-flows.row.depreciation-and-amortization	207.1	151.2	143.7	154.5	152.8	172	166.5	160.4	130.8	112.8	108.3	107.6	106.7	103.5	89	72.8	69	64	57.9	48.9	46.9	37.9	27.1	26.5	30.9	17.2
cash-flows.row.deferred-income-tax	7.5	3.7	-4.7	0.2	-1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-863.7	34.1	47.7	3.5	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-449.5	72.6	-48.4	82.7	96.8	-34.7	-65	-140.3	-332	-228.2	-88.5	-59	-156.9	3.6	-33.1	-62.8	-1.1	68	1.8	-62.9	-44.5	-41.7	59.3	-46.3	-197.8	-314.4
cash-flows.row.account-receivables	-430.9	140.6	-97.7	2.3	-43.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-55.5	-124.7	-3.4	97.3	269.7	73.7	71.9	-99.4	-330.1	-287	-110.4	-28.6	-3.3	-17.3	-31.5	-0.1	-5.4	-0.3	0.8	-14	-30.7	2.6	-25.5	-24.7	-18.3	-11.1
cash-flows.row.account-payables	37	52.9	57.5	-17.1	-128.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	3.7	-4.7	0.2	-1.3	-108.4	-136.9	-40.9	-2	58.7	21.9	-30.4	-153.6	20.9	-1.6	-62.7	4.2	68.4	1	-48.9	-13.9	-44.3	84.8	-21.7	-179.4	-303.2
cash-flows.row.other-non-cash-items	815.4	-980.3	-312.3	21.1	93	-99.2	19.6	66.5	5.7	44.8	21.9	86.1	-367.8	-120.1	42.6	37.7	-22.6	12.7	14.5	102	4.9	-8.6	0.3	0.9	0.2	-10.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-348.1	-491.6	-600.7	-479.6	-293.1	-773.1	-185.5	-411.5	-400.1	-106.1	-190.4	-241.8	-88.8	-72.7	-79.1	-56.7	-258.3	-286.9	-119.4	-49.1	-57.9	-89.4	-88.7	-52.5	-241	-16.5
cash-flows.row.acquisitions-net	0.4	0	20.4	-28.1	0	778.4	0.2	412.1	-0.1	0	0	241.9	0	73.2	19.7	0	0	0	0	0	0	0	0	0	241	0.1
cash-flows.row.purchases-of-investments	-238.1	-1153.5	-844.5	-510	-438	-518	-1244	-738.9	-1.8	0	-34.4	-17.2	0	-36.1	79.4	0	0	-9.7	0	-6.9	-161.9	-9.5	0	0	-2.5	-28.9
cash-flows.row.sales-maturities-of-investments	240.6	1992.8	1458.9	399.9	579.1	536	1321.2	312.1	48.7	0	0	14.1	456.2	143.9	51.3	0	84.8	0	0	0	0	0	0	0	0.5	0
cash-flows.row.other-investing-activites	0	-3.7	0	1.2	-0.4	-773.1	1.7	-411.5	-225.2	0	56.4	-241.8	0.1	-72.7	-79.1	0	0	0	0	0	0	0.5	0	-1	-241	4.2
cash-flows.row.net-cash-used-for-investing-activites	-345.2	344	34.1	-616.6	-152.5	-749.7	-106.5	-837.9	-578.4	-106	-168.3	-244.9	367.4	35.7	-7.7	-56.7	-173.5	-296.6	-119.4	-55.9	-219.8	-98.4	-88.7	-53.5	-242.9	-41.1
cash-flows.row.debt-repayment	-150	0	0	-400	-851.3	-501.3	-1019.3	-1396.9	-359.3	-362.3	-98.3	-102.3	-171.8	-275.5	-332.5	-324.6	-181.7	-458.4	-195.5	-170.2	-82	-97	-5.5	-20.6	-41.7	-101.4
cash-flows.row.common-stock-issued	0	0	77.4	59.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	-59.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-495.9	-1095.8	-425	-413.7	-427.4	-355.7	-299.9	-271.8	-247.1	-222.6	-181.2	-169.9	-16.6	-22.5	-32.2	-23.7	-19.2	-16	-18.2	-19.3	-86.7	-1.5	-32.7	-1.1	-4.4	-6.9
cash-flows.row.other-financing-activites	422	-188.3	-348	333	324.5	649.3	561	1804.2	900.3	470.9	318.6	204.4	63	118	234.3	321.7	254.1	593.6	254.9	242.5	328	177.9	5.3	3.8	305.6	336.9
cash-flows.row.net-cash-used-provided-by-financing-activities	-224	-1284.1	-695.6	-480.8	-954.2	-207.7	-758.2	135.5	293.9	-114	39	-67.8	-125.4	-180	-130.4	-26.5	53.2	119.2	41.2	53	159.3	79.5	-32.9	-17.9	259.5	228.6
cash-flows.row.effect-of-forex-changes-on-cash	0.6	0	0	0	0	0	0	0	0.3	0	-0.3	-1	-5.7	0	0	-35.6	52.6	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	316.1	-77	473	94.9	45.5	-80.5	96.5	23.4	10.3	-14.2	91.5	-119.4	181.2	16.1	28.1	-26.5	53.2	-19.4	14	10.2	-14.9	13	-3.9	-42.3	-78.5	-29.5
cash-flows.row.cash-at-end-of-period	1104.2	788.1	865	392	297.1	251.7	332.1	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	-26.5	53.2	8.9	28.3	14.3	4.1	19	6.1	9.8	54.1	132.6
cash-flows.row.cash-at-beginning-of-period	788.1	865	392	297.1	251.7	332.1	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	18.6	0	0	28.3	14.3	4.1	19	6	10	52.1	132.6	162.1
cash-flows.row.operating-cash-flow	884.7	863.1	1134.5	1192.3	1152.2	876.9	961.2	725.8	294.6	205.9	221.1	194.3	-55.1	160.4	166.2	92.3	120.9	158	92.2	13.2	45.5	32	117.7	29.1	-95.1	-217
cash-flows.row.capital-expenditure	-348.1	-491.6	-600.7	-479.6	-293.1	-773.1	-185.5	-411.5	-400.1	-106.1	-190.4	-241.8	-88.8	-72.7	-79.1	-56.7	-258.3	-286.9	-119.4	-49.1	-57.9	-89.4	-88.7	-52.5	-241	-16.5
cash-flows.row.free-cash-flow	536.6	371.5	533.8	712.7	859	103.9	775.7	314.2	-105.5	99.8	30.7	-47.5	-143.9	87.7	87.1	35.6	-137.4	-128.9	-27.2	-35.9	-12.4	-57.4	29	-23.3	-336.1	-233.5

Kasumiaruande rida

Tonghua Dongbao Pharmaceutical Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 600867.SS brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	3061.4	2778.5	3267.9	2892.2	2777.1	2692.9	2545.3	2040.4	1669.3	1451.3	1204.2	991.5	784.5	637.8	573.9	551	470	401.6	329.7	307.8	298.7	280.6	205.9	199.1	219.7	218.9	205.4	223.8	212.2	132
income-statement-row.row.cost-of-revenue	689.7	617.5	575.7	588.4	721.5	745	644.5	491.9	412.9	452	385.4	357.3	295.4	243.4	245.2	262.2	242.2	217.7	192.3	168.5	151.1	138.1	116.8	103.3	79.8	59.7	57.3	62.8	49.5	0
income-statement-row.row.gross-profit	2371.6	2160.9	2692.2	2303.8	2055.6	1947.9	1900.9	1548.5	1256.4	999.3	818.8	634.2	489.1	394.3	328.7	288.9	227.8	184	137.4	139.3	147.6	142.4	89.1	95.8	139.9	159.2	148.1	161	162.7	132
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-5.6	145.3	171.8	99	121.9	-15.5	-13.2	20.2	1.3	3.1	6.2	18.2	4.1	8.5	27.8	7.3	11.7	3.4	2.8	3.3	1.3	2.4	5.2	11.5	23.9	17.3	0.3	0.9	0.5	0.2
income-statement-row.row.operating-expenses	1101.1	1270.4	1420.7	1163.9	1101.4	957.8	897.8	742.2	683.7	635.5	592.6	500.5	434.4	324	232.6	192.2	174.9	124.9	102.4	173.5	106.2	96.1	60.6	51.5	70.2	65.3	50.6	47.5	61.9	0.2
income-statement-row.row.cost-and-expenses	1790.9	1887.9	1996.3	1752.2	1822.9	1702.8	1542.3	1234	1096.6	1087.5	978	857.8	729.8	567.4	477.8	454.3	417.1	342.5	294.7	342	257.3	234.3	177.4	154.7	150	125	107.9	110.3	111.4	0.2
income-statement-row.row.interest-income	-11.7	13.9	8.1	4.7	7.2	3.3	1.6	0.8	2.1	0.7	0.8	0.9	0.4	0.1	0.1	0.1	0.1	0.8	2.2	2.4	2.2	1.8	1.4	7.2	0	0	0	0	0	0
income-statement-row.row.interest-expense	4.5	0.3	0.2	10.2	20.6	13.5	15.5	44.6	18.2	27.5	17.6	13.8	16.6	22.5	32.2	23.7	19.3	16	16.2	17.4	6	0.7	0.3	0.3	-6.2	-2.4	-7.4	-3.6	-0.3	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	6.2	0.6	-14.8	-72.5	-15.4	-12.6	-30	-47.4	-2.2	-40	-14.5	-66.7	372.2	128.5	-15.7	-31.3	34.1	-40.5	-14.4	-40	1.9	5.8	3	17.5	21.9	28.8	7.2	3.6	-1.5	-59.7
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-5.6	145.3	171.8	99	121.9	-15.5	-13.2	20.2	1.3	3.1	6.2	18.2	4.1	8.5	27.8	7.3	11.7	3.4	2.8	3.3	1.3	2.4	5.2	11.5	23.9	17.3	0.3	0.9	0.5	0.2
income-statement-row.row.total-operating-expenses	6.2	0.6	-14.8	-72.5	-15.4	-12.6	-30	-47.4	-2.2	-40	-14.5	-66.7	372.2	128.5	-15.7	-31.3	34.1	-40.5	-14.4	-40	1.9	5.8	3	17.5	21.9	28.8	7.2	3.6	-1.5	-59.7
income-statement-row.row.interest-expense	4.5	0.3	0.2	10.2	20.6	13.5	15.5	44.6	18.2	27.5	17.6	13.8	16.6	22.5	32.2	23.7	19.3	16	16.2	17.4	6	0.7	0.3	0.3	-6.2	-2.4	-7.4	-3.6	-0.3	0
income-statement-row.row.depreciation-and-amortization	207.1	156.6	156.1	84.9	171.6	172	166.5	160.4	130.8	112.8	108.3	107.6	106.7	103.5	89	72.8	69	64	57.9	48.9	46.9	37.9	27.1	26.5	30.9	17.2	-7.8	-4.6	-2.6	59.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1270.5	1828.9	1549.3	1180.7	967.8	993	986.2	738.9	569.2	327.4	206.6	49	423.1	190.4	52.7	58.3	75.5	22.6	22.3	-71.1	45.6	52.6	36.9	55.1	84.5	105.7	105.3	118.1	103.4	72.1
income-statement-row.row.income-before-tax	1276.7	1829.5	1534.5	1108.1	952.5	977.5	973	758.9	570.5	323.8	211.8	67.1	426.9	198.9	80.4	65.4	87	22.3	22.8	-70.9	45.1	53.5	36.8	64.2	100	122.8	105.2	118	101.6	72.2
income-statement-row.row.income-tax-expense	198	247.7	225.9	177.8	142.9	138.6	132.9	119.7	80.5	47.3	32.3	7.4	63.9	25.5	12.7	20.9	11.4	9	4.8	3.9	6.9	9.2	5.7	16.2	28.4	32.2	14.5	36.5	33.5	23.8
income-statement-row.row.net-income	1167.8	1581.9	1308.3	929.9	811.2	838.6	836.6	640.9	493	279.8	183.9	62.7	364	178.4	73.7	46.8	77.4	12.1	16.2	-78.2	36.1	40	29.3	46.3	67.6	92.6	90.6	81.5	68.1	48.4